All PlansCoverageLow impact
Adoptive Immunotherapy
Blue Cross & Blue Shield of Mississippi·MS · Oncology, Hematology·Medical Policy
We identified it
Jun 20, 2026
Summary
All adoptive immunotherapy techniques for cancer treatment (including various cellular therapies and immunological treatments) are classified as investigational and not covered. This policy confirms that these experimental cancer treatments will not be reimbursed by the insurance plan.
Action Required
Immediately: Billing team should be aware that all adoptive immunotherapy procedures for cancer treatment are considered investigational and will be denied. Inform oncology providers that these treatments are not covered and patients should be notified of non-coverage before treatment begins.